{"id":269292,"date":"2025-10-01T13:44:16","date_gmt":"2025-10-01T13:44:16","guid":{"rendered":"https:\/\/www.europesays.com\/us\/269292\/"},"modified":"2025-10-01T13:44:16","modified_gmt":"2025-10-01T13:44:16","slug":"liquid-filtration-for-pharmaceutical-market-competitive-and-value-chain-analysis-insight","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/269292\/","title":{"rendered":"Liquid Filtration for Pharmaceutical Market Competitive and Value Chain Analysis Insight"},"content":{"rendered":"

<\/p>\n

According to Towards
\nHealthcare data, the global liquid
\nfiltration for pharmaceuticals market<\/b><\/a> is
\ngrowing quickly and is expected to generate hundreds of millions in revenue
\nbetween 2025 and 2034. This growth is being driven by rising investments,
\ncontinuous innovation, and increasing demand from multiple industries.<\/p>\n

Several factors contribute to
\nmarket growth, including the increasing development of biologics<\/b><\/a> and targeted therapy, and advancements in manufacturing
\ntechnologies. The demand for personalized medicines is increasing due to a rise
\nin chronic disorders and the geriatric population. Government bodies provide funding
\nfor installing advanced manufacturing technologies for pharmaceutical<\/b><\/a> and biotechnology products.<\/p>\n

<\/p>\n

The Complete Study
\nis Now Available for Immediate Access | Download the Sample Pages of this
\nReport @\u00a0 <\/b>https:\/\/www.towardshealthcare.com\/download-sample\/5934<\/b><\/a><\/p>\n

The Liquid Filtration for Pharmaceutical
\nMarket: Highlights<\/b><\/p>\n

\u27a2 North America dominated the global market share by 40% in
\n2024.<\/p>\n

\u27a2 Asia-Pacific is expected to witness the fastest growth
\nduring the predicted timeframe.<\/p>\n

\u27a2 By type of filtration technology, the membrane filtration
\nsegment held a dominant revenue share of the market in 2024.<\/p>\n

\u27a2 By type of filtration technology, the ultrafiltration
\nsub-segment is expected to grow at the fastest CAGR in the market during the
\nforecast period.<\/p>\n

\u27a2 By filter media type, the polyethersulfone (PES) segment
\naccounted for the highest revenue share of the market in 2024.<\/p>\n

\u27a2 By filter media type, the polyvinylidene fluoride (PVDF)
\nsegment is expected to witness the fastest growth in the liquid filtration for
\npharmaceutical market over the forecast period.<\/p>\n

\u27a2 By application, the sterile filtration segment held a major
\nrevenue share of the market in 2024.<\/p>\n

\u27a2 By application, the clarification filtration segment is
\nexpected to expand rapidly.<\/p>\n

\u27a2 By end-user, the pharmaceutical manufacturers segment led
\nthe market in 2024.<\/p>\n

\u27a2 By end-user, the contract manufacturing organizations
\n(CMOs) segment is expected to show the fastest growth in the upcoming years.<\/p>\n

\u27a2 By filtration equipment type, the filter cartridges segment
\ncontributed the biggest revenue share of the market in 2024.<\/p>\n

\u27a2 By filtration equipment type, the filter capsules segment
\nis expected to grow with the highest CAGR in the market during the studied
\nyears. <\/p>\n

What is Liquid Filtration for
\nPharmaceuticals?<\/b><\/p>\n

The liquid filtration for
\npharmaceutical market refers to the development and distribution of special
\nfilters to remove impurities from pharmaceutical products during manufacturing.
\nFilters eliminate contaminants, such as bacteria, viruses, dust, dirt, and
\nother debris, to improve product quality. The various types of filters used in
\nthe pharmaceutical industry include membrane, depth, cartridge, bag, and
\nactivated carbon. The selection of the filters depends on the type of
\npharmaceutical to be manufactured.<\/p>\n

You can place an
\norder or ask any questions, please feel free to contact us at <\/b>sales@towardshealthcare.com<\/b><\/a><\/p>\n

Advanced Membrane Technologies:
\nMajor Potential<\/b><\/p>\n

Advancements in membrane
\ntechnologies have emerged as a major potential in developing innovative filters
\nwith greater efficacy and reduced complexity. Nanofiltration and membrane
\nfiltration provide superior filtration efficiency as they are semi-permeable
\nfilters with extremely fine pores. They offer numerous benefits, such as
\nincreased durability, fouling resistance, and higher permeability.
\nAdditionally, scientists develop novel filter materials like polyethersulfone
\n(PES) and polyvinylidene fluoride (PVDF) to optimize the filtration process.<\/p>\n

High Cost: Major Limitation<\/b><\/p>\n

The installation and maintenance
\nof filter materials for liquid filtration, especially at large-scale
\noperations, are highly expensive. Innovative filter materials are more costly
\nthan conventional filter materials. This limits the affordability of numerous
\npharmaceutical and biotech companies from low- and middle-income countries<\/b><\/a>, restricting market growth.<\/p>\n

The Liquid Filtration for
\nPharmaceutical Market: Regional Analysis<\/b><\/p>\n

North America held a major revenue
\nshare of the market by 40% in 2024. The market in North America is driven by
\nthe strong presence of leading pharmaceutical and biotech companies and a
\nrobust healthcare infrastructure. Government organizations provide funding for
\ninstalling advanced filter systems. Favorable regulatory policies and
\nincreasing collaborations among key players propel market growth. Furthermore,
\nthe demand for personalized medicines<\/b><\/a> and the increasing number of contract development and
\nmanufacturing organizations (CDMOs) foster the market.<\/p>\n

The U.S. is home to over 5,000
\npharmaceutical companies and 3,000 biotechnology companies that deliver
\nhigh-quality products. Key players, such as Eli Lilly and Company, Pfizer,
\nInc., and AbbVie, Inc., are major contributors to the pharmaceutical sector in
\nthe U.S. The filtration system should comply with the Food and Drug
\nAdministration (FDA) and the United States Pharmacopoeia (USP) guidelines.<\/p>\n

The Canadian pharmaceutical sector
\nranks sixth globally, with a 2.1% share of the global market. This is due to increasing
\nmanufacturing activities, burgeoning drug sales, and expanding trade policies
\nwith foreign nations. In 2023, the total drug sales in Canada were $42.1
\nbillion, including patented and non-patented drugs.<\/p>\n

Asia-Pacific is expected to
\ngrow at the fastest CAGR in the market during the forecast period.<\/b> <\/p>\n

The liquid filtration for
\npharmaceutical market is experiencing significant expansion, with the
\nburgeoning pharmaceutical and biotech sector and favorable government support.
\nAsia-Pacific countries like China, India, and Japan have suitable manufacturing
\ninfrastructure, encouraging foreign players to set up their manufacturing
\nfacilities in these countries. The increasing number of pharmaceutical and
\nbiotech startups and venture capital investments contributes to market growth. <\/p>\n

China boasts more than 10,000
\npharmaceutical companies. According to the latest J.P. Morgan report, 27% of
\nthe total global big pharma deals with over $50 million originated from China
\nin 2024. Additionally, around 39% of the total global big pharma funding of
\nover $50 million was paid to Chinese firms in 2024.<\/p>\n

Download the single region market report
\n@ <\/b>https:\/\/www.towardshealthcare.com\/price\/5934<\/b><\/a><\/p>\n

The Liquid Filtration for
\nPharmaceutical Market: Segmentation Analysis<\/b><\/p>\n

By Type of Filtration
\nTechnology<\/b><\/p>\n

The membrane filtration segment
\ndominated the market in 2024. This segment dominated because membrane filters
\nhave a lower chance of clogging during sterile filtration. Membrane filters are
\nplastic semi-permeable membranes that separate products using a driving force.
\nDifferent types of membrane filtration techniques include ultrafiltration,
\nnanofiltration, reverse osmosis, and microfiltration. They offer numerous
\nbenefits, including prolonged filtration and high speed.<\/p>\n

The ultrafiltration sub-segment is
\nexpected to expand rapidly. The membrane filtration technologies are
\ncategorized based on the pore size of the filters. Ultrafilters have a pore
\nsize of 0.002 to 0.1. They are primarily used to filter microorganisms, humic
\nmaterials, and some viruses from pharmaceuticals. The demand for
\nultrafiltration is increasing as it does not require pH adjustments or
\ndisinfection.<\/p>\n

By Filter Media Type<\/b><\/p>\n

The polyethersulfone (PES) segment
\nheld the largest revenue share of the liquid filtration for pharmaceutical
\nmarket in 2024. This is due to the hydrophilic and low protein-binding ability
\nof PES. PES membrane filters are commonly used for tissue culture media
\nsterilization and other life science applications<\/b><\/a>. They are comparatively cost-effective and have a high
\nretention factor. The hydrophilic nature of the filter allows the media to
\nprovide lower pressure loss, ultimately increasing its shelf-life.<\/p>\n

The polyvinylidene fluoride (PVDF)
\nsegment is expected to grow at the fastest CAGR in the market during the
\nforecast period. PVDF is widely used for filtering gases or ventilation without
\nmoisture blockage. PVDF membrane filters can be either hydrophilic or
\nhydrophobic, with high chemical compatibility and no protein adsorption. They
\nare installed to achieve the highest requirements without the need for wetting
\nagents.<\/p>\n

Get the latest insights on life science
\nindustry segmentation with our Annual Membership: <\/b>https:\/\/www.towardshealthcare.com\/get-an-annual-membership<\/b><\/a><\/p>\n

By Application<\/b><\/p>\n

The sterile filtration segment
\nheld a dominant presence in the liquid filtration for pharmaceutical market in
\n2024. This is due to the need for highly pure and contamination-free
\npharmaceutical products. Products contaminated with microorganisms may cause
\nserious health problems in patients. Thus, regulatory agencies impose stringent
\nregulations on the presence of microorganisms in pharmaceuticals. The main
\nobjective of sterile filtration is to maintain product integrity.<\/p>\n

The clarification filtration
\nsegment is expected to grow with the highest CAGR in the market during the
\nstudied years. Clarification filtration is a type of prefiltration step to
\nremove visual impurities that can affect product quality. Prefilters remove the
\nmajority of contaminants from the product and enhance the shelf-life of the
\nmain filters by imposing less load on final filtration. This ultimately saves
\nthe cost of manufacturers.<\/p>\n

By End-User<\/b><\/p>\n

The pharmaceutical manufacturers
\nsegment contributed the biggest revenue share of the liquid filtration for
\npharmaceutical market in 2024. Pharmaceutical companies have a favorable
\nmanufacturing infrastructure to conduct in-house manufacturing of
\npharmaceuticals. They have suitable capital investment to install advanced
\nfiltration systems. They continuously expand their biopharmaceutical area to
\nfocus on the manufacturing of biologics and other complex therapeutics.<\/p>\n

The contract manufacturing
\norganizations (CMOs) segment is expected to witness the fastest growth in the
\nmarket over the forecast period. Large pharmaceutical companies outsource their
\nmanufacturing capabilities to CMOs to focus on their core competencies, such as
\nproduct sales and marketing. Small- and medium-sized enterprises collaborate
\nwith CMOs as they lack specialized manufacturing infrastructure.<\/p>\n

By Filtration Equipment Type<\/b><\/p>\n

The filter cartridges segment
\naccounted for the highest revenue share of the liquid filtration for
\npharmaceutical market in 2024. Filter cartridges are tube-like, structured
\nfiltration devices that are used to trap solid debris suspended in a liquid.
\nCartridge filters are designed from a variety of metallic and non-metallic
\nmaterials. Some common examples include cellulose, polypropylene, activated
\ncarbon, and ceramic. They are used in the pharmaceutical industry to maintain
\nsterility and purity in the manufacturing of pharmaceuticals.<\/p>\n

The filter capsules segment is
\nexpected to show the fastest growth in the upcoming years. Filter capsules are
\nprimarily used for small-scale applications and in places with space
\nconstraints. Laboratories use them for venting and gas filtration of biopharmaceutical<\/b><\/a>
\nprocesses. Filter capsules are easier to use as they are self-contained, and
\nthe installation is straightforward and quick.<\/p>\n

Become a valued research partner with us
\n– <\/b>https:\/\/www.towardshealthcare.com\/schedule-meeting<\/b><\/a><\/p>\n

Top Companies and Their Contributions
\nto the Market<\/b><\/p>\n\n\n

Companies<\/b><\/p>\n<\/td>\n\n

Contributions & Offerings<\/b><\/p>\n<\/td>\n<\/tr>\n\n\n

Avantor Sciences<\/p>\n<\/td>\n\n

Avantor offers a wide range of filtration solutions, from
\n filters to custom, complex filter assemblies for sterility and bioburden
\n reduction.<\/p>\n<\/td>\n<\/tr>\n\n\n

Brother Filtration<\/p>\n<\/td>\n\n

Brother Filtration is a leading manufacturer of
\n high-quality filtration products for diverse applications, including
\n biopharmaceuticals.<\/p>\n<\/td>\n<\/tr>\n\n\n

Parker Hannifin Corporation<\/p>\n<\/td>\n\n

Parker offers filtration solutions for complex
\n contaminant management issues through its Industrial Process Filtration
\n Division.<\/p>\n<\/td>\n<\/tr>\n\n\n

Koch Membrane Systems, Inc.<\/p>\n<\/td>\n\n

Koch Membrane Systems develops and manufactures spiral,
\n tubular, and hollow-fiber membranes.<\/p>\n<\/td>\n<\/tr>\n

\u00a0<\/p>\n

Liquid Filtration for
\nPharmaceutical Market Top Companies<\/b><\/p>\n

<\/b><\/p>\n

\u2022\u00a0 Avantor Sciences<\/p>\n

\u2022\u00a0 Brother Filtration<\/p>\n

\u2022\u00a0 Parker Hannifin Corporation<\/p>\n

\u2022\u00a0 Koch Membrane Systems, Inc.<\/p>\n

\u2022\u00a0 Pall Corporation<\/p>\n

\u2022\u00a0 Sartorius AG<\/p>\n

\u2022\u00a0 Merck KGaA<\/p>\n

\u2022\u00a0 3M Company<\/p>\n

\u2022\u00a0 Atlas Filtri<\/p>\n

\u2022\u00a0 Pentair plc<\/p>\n

\u2022\u00a0 Dow Water & Process Solutions<\/p>\n

Recent Developments in the
\nLiquid Filtration for Pharmaceutical Market<\/b><\/p>\n

\u27a2 In June 2025, Cytiva Life Sciences announced the completion
\nof its expansion projects in the U.S., Europe, and Asia through an investment
\nof $1.6 billion. The expansion is part of Cytiva\u2019s long-term growth plan and
\nin-region manufacturing strategy. <\/p>\n

\u27a2 In December 2024, Ahlstrom announced the acquisition of
\nErtelAlsop to strengthen its position in the life science filtration market,
\nallowing the company to enter the depth filtration space. ErtelAlsop will
\nbecome part of Ahlstrom\u2019s Filtration and Life Sciences business.<\/p>\n

\u27a2 In June 2024, Asahi Kasei announced the launch of a
\nmembrane system, MicrozaTM hollow-fiber membrane, to produce water for
\ninjection (WFI). The system was developed as an alternative to conventional
\ndistillation processes for the production of WFI for water treatment and
\nfiltration of liquid products.<\/p>\n

Download the Competitive Landscape market
\nreport @<\/b> https:\/\/www.towardshealthcare.com\/price\/5934<\/b><\/a><\/p>\n

Liquid Filtration for
\nPharmaceutical Market Segmentation<\/b><\/p>\n

By Type of Filtration
\nTechnology<\/b><\/p>\n

\u2022 Membrane Filtration<\/p>\n

\u25cb
\nMicrofiltration<\/p>\n

\u25cb
\nUltrafiltration<\/p>\n

\u25cb
\nNanofiltration<\/p>\n

\u25cb
\nReverse Osmosis<\/p>\n

\u2022 Depth Filtration<\/p>\n

\u25cb
\nCellulose-based Depth Filters<\/p>\n

\u25cb
\nSynthetic Depth Filters<\/p>\n

\u2022 Pre-filtration\/Coarse Filtration<\/p>\n

\u2022 Crossflow Filtration<\/p>\n

\u2022 Others<\/p>\n

\u25cb
\nGravity Filtration<\/p>\n

\u25cb
\nScreen Filtration<\/p>\n

By Filter Media Type<\/b><\/p>\n

\u2022 Polyethersulfone (PES)\u202f<\/p>\n

\u2022 Polyvinylidene Fluoride (PVDF)<\/p>\n

\u2022 Nylon<\/p>\n

\u2022 Polytetrafluoroethylene (PTFE)<\/p>\n

\u2022 Cellulose Acetate (CA)<\/p>\n

\u2022 Polypropylene (PP)<\/p>\n

\u2022 Others<\/p>\n

By Application<\/b><\/p>\n

\u2022 Sterile Filtration<\/p>\n

\u2022 Clarification Filtration<\/p>\n

\u2022 Bioburden Reduction<\/p>\n

\u2022 Solvent Filtration<\/p>\n

\u2022 Cell Culture Filtration<\/p>\n

\u2022 Others<\/p>\n

By End-User<\/b><\/p>\n

\u2022 Pharmaceutical Manufacturers<\/p>\n

\u2022 Contract Manufacturing Organizations (CMOs)<\/p>\n

\u2022 Biopharmaceutical Companies<\/p>\n

\u2022 Research & Development Institutes<\/p>\n

\u2022 Others<\/p>\n

By Filtration Equipment Type<\/b><\/p>\n

\u2022 Filter Cartridges<\/p>\n

\u2022 Filter Capsules<\/p>\n

\u2022 Filter Plates & Frames<\/p>\n

\u2022 Filter Housings<\/p>\n

\u2022 Filter Bags<\/p>\n

\u2022 Others<\/p>\n

By Region<\/b><\/p>\n

\u2022 North America<\/p>\n

\u25cb
\nU.S.<\/p>\n

\u25cb
\nCanada<\/p>\n

\u2022 Asia Pacific<\/p>\n

\u25cb
\nChina<\/p>\n

\u25cb
\nJapan<\/p>\n

\u25cb
\nIndia<\/p>\n

\u25cb
\nSouth Korea<\/p>\n

\u25cb
\nThailand<\/p>\n

\u2022 Europe<\/p>\n

\u25cb
\nGermany<\/p>\n

\u25cb
\nUK<\/p>\n

\u25cb
\nFrance<\/p>\n

\u25cb
\nItaly<\/p>\n

\u25cb
\nSpain<\/p>\n

\u25cb
\nSweden<\/p>\n

\u25cb
\nDenmark<\/p>\n

\u25cb
\nNorway<\/p>\n

\u2022 Latin America<\/p>\n

\u25cb
\nBrazil<\/p>\n

\u25cb
\nMexico<\/p>\n

\u25cb
\nArgentina<\/p>\n

\u2022 Middle East and Africa (MEA)<\/p>\n

\u25cb
\nSouth Africa<\/p>\n

\u25cb
\nUAE<\/p>\n

\u25cb
\nSaudi Arabia<\/p>\n

\u25cb
\nKuwait <\/p>\n

Immediate Delivery
\nAvailable | Buy This Premium Research @ <\/b>https:\/\/www.towardshealthcare.com\/price\/5934<\/b><\/a><\/p>\n

Access our exclusive,
\ndata-rich dashboard dedicated to the healthcare market – built specifically for
\ndecision-makers, strategists, and industry leaders. The dashboard features
\ncomprehensive statistical data, segment-wise market breakdowns, regional
\nperformance shares, detailed company profiles, annual updates, and much more.
\nFrom market sizing to competitive intelligence, this powerful tool is one-stop
\nsolution to your gateway.<\/p>\n

Access the
\nDashboard: <\/b>https:\/\/www.towardshealthcare.com\/access-dashboard<\/b><\/a><\/p>\n

About Us<\/b><\/p>\n

Towards Healthcare<\/b> is a leading global provider of technological
\nsolutions, clinical research services, and advanced analytics, with a strong emphasis on life science research<\/b><\/a>. Dedicated to advancing innovation in the life
\nsciences sector, we build strategic partnerships that generate actionable
\ninsights and transformative breakthroughs. As a global strategy consulting
\nfirm, we empower life science leaders to gain a competitive edge, drive
\nresearch excellence, and accelerate sustainable growth.<\/p>\n

You can place an
\norder or ask any questions, please feel free to contact us at <\/b>sales@towardshealthcare.com<\/b><\/a><\/p>\n

Europe Region: <\/b>+44 778 256 0738<\/p>\n

North America
\nRegion: <\/b>+1 8044 4193 44<\/p>\n

APAC Region<\/b>: +91 9356 9282 04<\/p>\n

Web:\u00a0<\/b>https:\/\/www.towardshealthcare.com<\/b><\/a><\/p>\n

Find us on social
\nplatforms:\u00a0<\/b>LinkedIn<\/b><\/a> |\u00a0<\/b>Twitter<\/b><\/a> |\u00a0<\/b>Instagram<\/b><\/a>
\n| <\/b>Medium<\/b><\/a> | <\/b>Pinterest<\/b><\/a><\/p>\n

Browse More of Towards Healthcare<\/b><\/a>:<\/b><\/p>\n

Gene Editing at
\nBristol Myers Squibb: <\/b>https:\/\/www.towardshealthcare.com\/companies\/gene-editing-bristol-myers-squibb-companies<\/b><\/a><\/p>\n

Stryker &
\nSiemens Healthineers with Robotic Stroke Solutions: <\/b>https:\/\/www.towardshealthcare.com\/companies\/stryker-siemens-neurovascular-robotics<\/b><\/a><\/p>\n

Top Global Players
\nin the Life Sciences Market in 2025: <\/b>https:\/\/www.towardshealthcare.com\/companies\/key-players-in-the-life-sciences-market<\/b><\/a><\/p>\n

Top Companies Innovating
\nin GLP-1 Obesity Treatments in 2025: <\/b>https:\/\/www.towardshealthcare.com\/companies\/top-companies-innovating-in-glp-1-obesity-treatments<\/b><\/a><\/p>\n

RaySearch &
\nRadiology Oncology Systems to Expand Cancer Care: <\/b>https:\/\/www.towardshealthcare.com\/companies\/raysearch-radiology-oncology-systems-partnership-companies<\/b><\/a><\/p>\n

Eli Lilly\u2019s Legal
\nBattle for Compounding Pharmacy Market: <\/b>https:\/\/www.towardshealthcare.com\/companies\/lilly-empower-compounding-pharmacy-companies<\/b><\/a><\/p>\n

Amgen and the GLP-1
\nObesity Market: <\/b>https:\/\/www.towardshealthcare.com\/companies\/amgen-maritide-glp1-obesity-2025-leaders<\/b><\/a><\/p>\n

Top Companies in the
\nCosmeceuticals Market: <\/b>https:\/\/www.towardshealthcare.com\/companies\/cosmeceuticals-market-companies<\/b><\/a><\/p>\n

Cardiovascular Drugs
\nMarket Key Players-Business: <\/b>https:\/\/www.towardshealthcare.com\/companies\/cardiovascular-drugs-companies<\/b><\/a><\/p>\n

U.S. Telehealth
\nCompanies and Market Trends Analysis: <\/b>https:\/\/www.towardshealthcare.com\/companies\/us-telehealth-companies<\/b><\/a><\/p>\n